Opus Genetics, Inc.
IRD
$4.91
-$0.28-5.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.87M | 3.08M | 2.88M | 4.37M | 4.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.87M | 3.08M | 2.88M | 4.37M | 4.30M |
| Cost of Revenue | 10.43M | 6.41M | 6.02M | 7.89M | 7.03M |
| Gross Profit | -6.56M | -3.33M | -3.14M | -3.52M | -2.73M |
| SG&A Expenses | 4.89M | 4.98M | 5.77M | 6.41M | 7.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.32M | 11.39M | 11.79M | 14.30M | 14.33M |
| Operating Income | -11.45M | -8.31M | -8.91M | -9.93M | -10.03M |
| Income Before Tax | -16.52M | -17.45M | -7.42M | -8.19M | -35.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.52M | -17.45M | -7.42M | -8.19M | -35.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.52M | -17.45M | -7.42M | -8.19M | -35.14M |
| EBIT | -11.45M | -8.31M | -8.91M | -9.93M | -10.03M |
| EBITDA | -11.44M | -8.30M | -8.89M | -9.92M | -10.03M |
| EPS Basic | -0.21 | -0.25 | -0.12 | -0.24 | -1.16 |
| Normalized Basic EPS | -0.13 | -0.15 | -0.07 | -0.15 | -0.15 |
| EPS Diluted | -0.21 | -0.25 | -0.12 | -0.24 | -1.16 |
| Normalized Diluted EPS | -0.13 | -0.15 | -0.07 | -0.15 | -0.15 |
| Average Basic Shares Outstanding | 80.59M | 70.64M | 63.38M | 33.88M | 30.36M |
| Average Diluted Shares Outstanding | 80.59M | 70.64M | 63.38M | 33.88M | 30.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |